Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE DAVOINE from Vorst, company number BE0444488642, closed financial year 2025 with a result of € -46,694 after tax. For that financial year PHARMACIE DAVOINE recorded a gross margin of € 359,938 and equity of € 144,505. Compared with financial year 2024, the result moved from € 95,876 to € -46,694. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.
€ 144,505
▼ 24% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -46,694
▼ still € 95,876 profit in 2024
Profit after tax over the fiscal year.
€ 26,051
▼ 66% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 82,505.
People and assets in 2025
3.5
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 212,912
€ 60,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 71,019
▼ 17% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 902,834
▲ 46% vs 2024
€ 102,089 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 391,440
▲ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 38,993
▲ 57% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 624,875 | € 652,035 | € 449,339 | € 359,938 | ▼ 20% |
| Profit after taxes | € 537,637 | € 524,030 | € 95,876 | € -46,694 | ▼ € 142,571 |
| Equity | € 191,093 | € 191,123 | € 191,200 | € 144,505 | ▼ 24% |
| Total debts | € 1,354,956 | € 1,441,481 | € 1,456,225 | € 1,832,306 | ▲ 26% |
| Cash | € 53,445 | € 107,617 | € 76,144 | € 26,051 | ▼ 66% |
| Land & buildings | € 409,916 | € 376,439 | € 406,687 | € 763,025 | ▲ 88% |
| Retained profit | € 129,093 | € 129,123 | € 129,200 | € 82,505 | ▼ 36% |
| Dividend | € 528,200 | € 524,000 | € 95,800 | € 0 | ▼ 100% |
| Bank debt | € 503,408 | € 489,291 | € 618,179 | € 902,834 | ▲ 46% |
| Balance sheet total | € 1,546,049 | € 1,632,604 | € 1,647,424 | € 1,976,811 | ▲ 20% |
| Employees (FTE) | - | 0.3 | 3.8 | 3.5 | ▼ 0.3 |
Key figures of PHARMACIE DAVOINE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DAVOINE?
What happened at PHARMACIE DAVOINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Clarexis & Co srl stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 46,694 (▼ € 142,571 vs 2024). filed late Source: NBB ↗
- Clarexis & Co srl became a director. NBB
- DAVOINE SRL became a director. NBB
- JEAN-CHRISTOPHE DAVOINE became a director. NBB
- New establishment in Jemeppe-sur-Sambre. KBO
- Start of the company according to the CBE. KBO
In short
From € 537,637 profit in 2022 to € 46,694 loss in 2025.
Paid € 17,346 in corporate taxes since 2022.
Best year ever: 2022, with € 537,637 profit.
On average € 102,800 of value added per employee in 2025.
A new publication or filing at PHARMACIE DAVOINE? We notify you, reason included.
Follow PHARMACIE DAVOINEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DAVOINE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DAVOINEBehind PHARMACIE DAVOINE are DAVOINE SRL and JEAN-CHRISTOPHE DAVOINE. The shares are held by DAVOINE (90%).
Directors
According to the 2025 annual accounts
since 2022
JEAN-CHRISTOPHE DAVOINE
Director
since 2021
Managing director · represented by Davoine Alexis
Also active at: PHARMACIE DUFRANE
since 2024 · until 2030
Shareholders
90%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kastanjestraat 21
1190 Vorst
Rue Boulanger-Duhayon 35
5190 Jemeppe-sur-Sambre
Active since 29 August 2000
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0444.488.642
- VAT number
- BE 0444.488.642
- Registered office
- Kastanjestraat 21, 1190 Vorst
- Names & denominations
- PHARMACIE DAVOINE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 26 June 1991
- Peppol
- Active · Active since 28 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Niet-gespecialiseerde detailhandel waarbij voedings- en genotmiddelen overheersen
Detailhandel in cosmetica en toiletartikelen
Overige niet-gespecialiseerde detailhandel in winkels in overwegend voedings- en genotmiddelen
Detailhandel in niet-gespecialiseerde winkels waarbij voedings- en genotmiddelen overheersen (verkoopsoppervlakte < 100 m²)